Empagliflozin

Listing ID #5222230

Empagliflozin is new molecule to fight type 2 diabetes. It is good inhibitor of sodium-glucose co-transporter 2 (sglt2; slc5a2) with antihyper glycemic activity. It improves glycemic control in adults with type 2 diabetes mellitus.
 
It is formulated as coated tablets and film-coated tablets for oral route of administration.
Empagliflozin is a sodium-dependent glucose transporter-2 inhibitor (sglt-2 inhibitor). The drug candidate leads to reductions in hepatic glucose production and amelioration of glucotoxicity.
It Is White Colour Powder With Purity More Than 99% And Have Boiling Point 665 C Degree And Flash Point Is 356 C Degree.